[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.112.64. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Medical News and Perspectives
August 11, 2004

Laura van ‘t Veer, PhD

JAMA. 2004;292(6):675. doi:10.1001/jama.292.6.675

Laura van ‘t Veer, PhD, and colleagues at the Netherlands Cancer Institute, Amsterdam, recently identified a 70-gene profile that could predict cancer recurrence in a subset of women who had node-negative breast cancer. Their studies will be the foundation of an upcoming clinical trial in Europe and Latin America that will use DNA microarray technology (which provides a snapshot of what genes are expressed, or active, in normal and cancerous cells) to help determine therapies for women with this disease (JAMA. 2004;291:2927-2930). She took a break during the American Society of Clinical Oncology annual meeting in New Orleans to talk about her work.

First Page Preview View Large
First page PDF preview
First page PDF preview
×